The Expression and Regulation of Chemerin in the Epidermis

Chemerin is a protein ligand for the G protein-coupled receptor CMKLR1 and also binds to two atypical heptahelical receptors, CCRL2 and GPR1. Chemerin is a leukocyte attractant, adipokine, and antimicrobial protein. Although chemerin was initially identified as a highly expressed gene in healthy skin keratinocytes that was downregulated during psoriasis, the regulation of chemerin and its receptors in the skin by specific cytokines and microbial factors remains unexplored. Here we show that chemerin, CMKLR1, CCRL2 and GPR1 are expressed in human and mouse epidermis, suggesting that this tissue may be both a source and target for chemerin mediated effects. In human skin cultures, chemerin is significantly downregulated by IL-17 and IL-22, key cytokines implicated in psoriasis, whereas it is upregulated by acute phase cytokines oncostatin M and IL-1β. Moreover, we show that human keratinocytes in vitro and mouse skin in vivo respond to specific microbial signals to regulate expression levels of chemerin and its receptors. Furthermore, in a cutaneous infection model, chemerin is required for maximal bactericidal effects in vivo. Together, our findings reveal previously uncharacterized regulators of chemerin expression in skin and identify a physiologic role for chemerin in skin barrier defense against microbial pathogens.

[1]  S. Muruganandan,et al.  Gpr1 is an active chemerin receptor influencing glucose homeostasis in obese mice. , 2014, The Journal of endocrinology.

[2]  M. Sperandio,et al.  Endothelial Cell–Derived Chemerin Promotes Dendritic Cell Transmigration , 2014, The Journal of Immunology.

[3]  M. Suárez-Fariñas,et al.  IL-17 Induces an Expanded Range of Downstream Genes in Reconstituted Human Epidermis Model , 2014, PloS one.

[4]  B. Zabel,et al.  Chemerin regulation and role in host defense. , 2014, American journal of clinical and experimental immunology.

[5]  F. Nestle,et al.  TLRs to cytokines: Mechanistic insights from the imiquimod mouse model of psoriasis , 2013, European journal of immunology.

[6]  Adam J Pawson,et al.  International Union of Basic and Clinical Pharmacology. LXXXVIII. G Protein-Coupled Receptor List: Recommendations for New Pairings with Cognate Ligands , 2013, Pharmacological Reviews.

[7]  David A. Martin,et al.  The IL-23/T17 pathogenic axis in psoriasis is amplified by keratinocyte responses. , 2013, Trends in immunology.

[8]  A. Schmidtchen,et al.  Chemerin Is an Antimicrobial Agent in Human Epidermis , 2013, PloS one.

[9]  Li-Hua Lian,et al.  IL-1R1 signaling facilitates Munro’s microabscess formation in psoriasiform imiquimod-induced skin inflammation , 2012, The Journal of investigative dermatology.

[10]  E. Butcher,et al.  Expression, Regulation, and Function of Atypical Chemerin Receptor CCRL2 on Endothelial Cells , 2012, The Journal of Immunology.

[11]  E. Butcher,et al.  Chemokine-like receptor 1 regulates skeletal muscle cell myogenesis. , 2012, American journal of physiology. Cell physiology.

[12]  T. Abe,et al.  Chemerin regulates β-cell function in mice , 2011, Scientific reports.

[13]  J. Renauld,et al.  IL-22 Is Required for Imiquimod-Induced Psoriasiform Skin Inflammation in Mice , 2011, The Journal of Immunology.

[14]  J. Magarian Blander,et al.  Detection of prokaryotic mRNA signifies microbial viability and promotes immunity , 2011, Nature.

[15]  E. Butcher,et al.  Regulation of Chemerin Chemoattractant and Antibacterial Activity by Human Cysteine Cathepsins , 2011, The Journal of Immunology.

[16]  M. Boguniewicz,et al.  TNF-α downregulates filaggrin and loricrin through c-Jun N-terminal kinase: role for TNF-α antagonists to improve skin barrier. , 2011, The Journal of investigative dermatology.

[17]  S. Parlee,et al.  Chemerin, a Novel Peroxisome Proliferator-activated Receptor γ (PPARγ) Target Gene That Promotes Mesenchymal Stem Cell Adipogenesis* , 2011, The Journal of Biological Chemistry.

[18]  M. Boguniewicz,et al.  TNF-alpha Down-Regulates Filaggrin and Loricrin Through c-Jun N-Terminal Kinase: Role for TNF Antagonists to Improve Skin Barrier , 2011 .

[19]  Todd Davidson,et al.  Generation of Pathogenic Th17 Cells in the Absence of TGF-β Signaling , 2010, Nature.

[20]  K. Goralski,et al.  Chemerin exacerbates glucose intolerance in mouse models of obesity and diabetes. , 2010, Endocrinology.

[21]  H. Randeva,et al.  Identification of Chemerin Receptor (ChemR23) in Human Endothelial Cells: , 2009 .

[22]  S. Durham,et al.  Th22 cells represent a distinct human T cell subset involved in epidermal immunity and remodeling. , 2009, The Journal of clinical investigation.

[23]  M. Parmentier,et al.  Mouse ChemR23 Is Expressed in Dendritic Cell Subsets and Macrophages, and Mediates an Anti-Inflammatory Activity of Chemerin in a Lung Disease Model1 , 2009, The Journal of Immunology.

[24]  R. Sobel,et al.  Chemokine-Like Receptor-1 Expression by Central Nervous System-Infiltrating Leukocytes and Involvement in a Model of Autoimmune Demyelinating Disease1 , 2009, The Journal of Immunology.

[25]  P. Arner,et al.  Chemerin Is a Novel Adipocyte-Derived Factor Inducing Insulin Resistance in Primary Human Skeletal Muscle Cells , 2009, Diabetes.

[26]  K. Mills,et al.  Interleukin-1 and IL-23 induce innate IL-17 production from gammadelta T cells, amplifying Th17 responses and autoimmunity. , 2009, Immunity.

[27]  E. Butcher,et al.  Regular paper on-line at: www.actabp.pl , 2009 .

[28]  L. Boon,et al.  Imiquimod-Induced Psoriasis-Like Skin Inflammation in Mice Is Mediated via the IL-23/IL-17 Axis1 , 2009, The Journal of Immunology.

[29]  E. Butcher,et al.  Potential role of chemerin in recruitment of plasmacytoid dendritic cells to diseased skin. , 2009, Biochemical and biophysical research communications.

[30]  M. Parmentier,et al.  Chemerin expression marks early psoriatic skin lesions and correlates with plasmacytoid dendritic cell recruitment , 2009, The Journal of experimental medicine.

[31]  S. Galli,et al.  Mast cell–expressed orphan receptor CCRL2 binds chemerin and is required for optimal induction of IgE-mediated passive cutaneous anaphylaxis , 2008, The Journal of experimental medicine.

[32]  R. Ransohoff,et al.  Scavenging roles of chemokine receptors: chemokine receptor deficiency is associated with increased levels of ligand in circulation and tissues. , 2008, Blood.

[33]  G. Barnea,et al.  The genetic design of signaling cascades to record receptor activation , 2008, Proceedings of the National Academy of Sciences.

[34]  E. Butcher,et al.  Chemerin, a Novel Adipokine That Regulates Adipogenesis and Adipocyte Metabolism* , 2007, Journal of Biological Chemistry.

[35]  M. Parmentier,et al.  The role of chemerin in the colocalization of NK and dendritic cell subsets into inflamed tissues. , 2007, Blood.

[36]  S. Chevalier,et al.  Oncostatin M Secreted by Skin Infiltrating T Lymphocytes Is a Potent Keratinocyte Activator Involved in Skin Inflammation1 , 2007, The Journal of Immunology.

[37]  G. Dubin,et al.  Staphylococcus aureus-Derived Staphopain B, a Potent Cysteine Protease Activator of Plasma Chemerin1 , 2007, The Journal of Immunology.

[38]  M. Blumenberg,et al.  A characteristic subset of psoriasis-associated genes is induced by oncostatin-M in reconstituted epidermis. , 2006, The Journal of investigative dermatology.

[39]  E. Butcher,et al.  Chemokine-like receptor 1 expression by macrophages in vivo: regulation by TGF-beta and TLR ligands. , 2006, Experimental hematology.

[40]  E. Butcher,et al.  Chemoattractants, extracellular proteases, and the integrated host defense response. , 2006, Experimental hematology.

[41]  E. Butcher,et al.  Chemerin Activation by Serine Proteases of the Coagulation, Fibrinolytic, and Inflammatory Cascades* , 2005, Journal of Biological Chemistry.

[42]  P. Kulig,et al.  Acute phase mediator oncostatin M regulates affinity of alpha1-protease inhibitor for concanavalin A in hepatoma-derived but not lung-derived epithelial cells. , 2005, Cytokine.

[43]  A. Gurney,et al.  IL-22 Inhibits Epidermal Differentiation and Induces Proinflammatory Gene Expression and Migration of Human Keratinocytes1 , 2005, The Journal of Immunology.

[44]  E. Butcher,et al.  Chemokine-Like Receptor 1 Expression and Chemerin-Directed Chemotaxis Distinguish Plasmacytoid from Myeloid Dendritic Cells in Human Blood1 , 2005, The Journal of Immunology.

[45]  M. Pfaffl,et al.  Determination of stable housekeeping genes, differentially regulated target genes and sample integrity: BestKeeper – Excel-based tool using pair-wise correlations , 2004, Biotechnology Letters.

[46]  Marc Parmentier,et al.  Specific Recruitment of Antigen-presenting Cells by Chemerin, a Novel Processed Ligand from Human Inflammatory Fluids , 2003, The Journal of experimental medicine.

[47]  F. Speleman,et al.  Accurate normalization of real-time quantitative RT-PCR data by geometric averaging of multiple internal control genes , 2002, Genome Biology.

[48]  Thomas D. Schmittgen,et al.  Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. , 2001, Methods.

[49]  H. Baumann,et al.  Endotoxin-induced Renal Inflammatory Response , 2000, The Journal of Biological Chemistry.

[50]  H. Jacobe,et al.  Tazarotene-induced gene 2 (TIG2), a novel retinoid-responsive gene in skin. , 1997, The Journal of investigative dermatology.

[51]  J. Potempa,et al.  Biosynthesis of α1-Proteinase Inhibitor by Human Lung-derived Epithelial Cells* , 1997, The Journal of Biological Chemistry.

[52]  J. Potempa,et al.  Stimulatory effect of inflammatory cytokines on alpha 1-antichymotrypsin expression in human lung-derived epithelial cells. , 1995, The Journal of clinical investigation.

[53]  S. Dower,et al.  Interleukin 1 binds to specific receptors on human keratinocytes and induces granulocyte macrophage colony-stimulating factor mRNA and protein. A potential autocrine role for interleukin 1 in epidermis. , 1988, The Journal of clinical investigation.

[54]  P. Chomczyński,et al.  Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. , 1987, Analytical biochemistry.

[55]  J. Potempa,et al.  Biosynthesis of alpha1-proteinase inhibitor by human lung-derived epithelial cells. , 1997, The Journal of biological chemistry.